IGFBP7 and acute kidney injury: Kashani K’s study demonstrated that NAGL was weaker than NephroCheck and urinary TIMP-2/IGFBP7, but stronger than plasma cystatin C and urine KIM-1 in predicting acute kidney injury [27].